Parallax Volatility Advisers
ARNA

Parallax Volatility Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Parallax Volatility Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,000
Closed -$654K – 3878
2018
Q2 		$654K Buy
+15,000
New +$645K ﹤0.01% 1203

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Parallax Volatility Advisers's ARNA Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2019, closing a stake of 130 shares — an estimated $5.96K sold.

Parallax Volatility Advisers first reported a position in ARNA in Q4 2017 and held it in 5 quarters. The position peaked at $1.19M in Q2 2018. 184 funds tracked by Wall St. Rank hold ARNA as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 130 Arena Pharmaceuticals Inc shares in Q1 2019, an estimated $5.96K.
  • Parallax Volatility Advisers first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Arena Pharmaceuticals Inc position peaked at $1.19M in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.